Your browser doesn't support javascript.
loading
Biochemical evidence for conformational variants in the anti-viral and pro-metastatic protein IFITM1.
Nekulová, Marta; Wyszkowska, Marta; Friedlová, Nela; Uhrík, Lukás; Zavadil Kokás, Filip; Hrabal, Václav; Hernychová, Lenka; Vojtesek, Borivoj; Hupp, Ted R; Szymanski, Michal R.
Affiliation
  • Nekulová M; Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic.
  • Wyszkowska M; Structural Biology Laboratory, Intercollegiate Faculty of Biotechnology of University of Gdansk and Medical University of Gdansk, University of Gdansk, 80-307 Gdansk, Poland.
  • Friedlová N; Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic.
  • Uhrík L; Department of Experimental Biology, Faculty of Science, Masaryk University, 625 00 Brno, Czech Republic.
  • Zavadil Kokás F; Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic.
  • Hrabal V; Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic.
  • Hernychová L; Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic.
  • Vojtesek B; Department of Experimental Biology, Faculty of Science, Masaryk University, 625 00 Brno, Czech Republic.
  • Hupp TR; Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic.
  • Szymanski MR; Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic.
Biol Chem ; 405(5): 311-324, 2024 May 27.
Article in En | MEDLINE | ID: mdl-38379409
ABSTRACT
Interferon induced transmembrane proteins (IFITMs) play a dual role in the restriction of RNA viruses and in cancer progression, yet the mechanism of their action remains unknown. Currently, there is no data about the basic biochemical features or biophysical properties of the IFITM1 protein. In this work, we report on description and biochemical characterization of three conformational variants/oligomeric species of recombinant IFITM1 protein derived from an Escherichia coli expression system. The protein was extracted from the membrane fraction, affinity purified, and separated by size exclusion chromatography where two distinct oligomeric species were observed in addition to the expected monomer. These species remained stable upon re-chromatography and were designated as "dimer" and "oligomer" according to their estimated molecular weight. The dimer was found to be less stable compared to the oligomer using circular dichroism thermal denaturation and incubation with a reducing agent. A two-site ELISA and HDX mass spectrometry suggested the existence of structural motif within the N-terminal part of IFITM1 which might be significant in oligomer formation. Together, these data show the unusual propensity of recombinant IFITM1 to naturally assemble into very stable oligomeric species whose study might shed light on IFITM1 anti-viral and pro-oncogenic functions in cells.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein Conformation / Antigens, Differentiation Limits: Humans Language: En Journal: Biol Chem Journal subject: BIOQUIMICA Year: 2024 Document type: Article Affiliation country: Czech Republic Country of publication: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein Conformation / Antigens, Differentiation Limits: Humans Language: En Journal: Biol Chem Journal subject: BIOQUIMICA Year: 2024 Document type: Article Affiliation country: Czech Republic Country of publication: Germany